logo-loader
viewAlgae Tec Ltd

Algae.Tec’s shares rise after licensing unique pharmaceutical delivery technology

Algae.Tec has signed a deal with a private Australian-based pharmaceutical delivery company.

a lab technician
Algae oil will be the base component

Algae.Tec Ltd’s (ASX:AEB) shares are trading circa 13% higher intra-day after licensing a patented mini emulsion-based delivery platform for pharmaceutical application.

The company has signed an agreement with a private Australian-based pharmaceutical delivery company, NS Technologies (NST) for the delivery platform technology.

Lower dosage with an effective outcome

The technology is one where a ‘mini-emulsion’ was developed to allow complex molecules to penetrate the epidermis skin layer, and enter the subdermal layer of the human body.

The mini-emulsion droplets filter through the epidermal layer, in an effective, “slow release” manner, allowing lower dosages, with an effective outcome.

This mini-emulsion base component requires a selected vegetable oil, which is ideally suited to specific algal oils.

Algae.Tec’s algal oils could be the base component

Under the agreement, Algae.Tec will acquire 19.9% of NST and exclusively license NST’s delivery platform technology for use across any medical application developed by Algae.Tec.

NST has also agreed to use AEB’s algae oil as the base component of its emulsion delivery platform.

The companies are aiming to develop a range of mini-emulsion pharmaceutical products for both human and veterinary purposes using selected algal oils.

READ: Algae.Tec to boost cash for medical cannabis cultivation plans

Quick facts: Algae Tec Ltd

Price: 0.009 AUD

ASX:AEB
Market: ASX
Market Cap: $8.77 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Jindalee Resources announces maiden lithium resource at McDermitt Lithium...

Jindalee Resources Limited (ASX:JRL) managing director Pip Darvall speaks to Proactive about the estimation of a maiden inferred mineral resource at its 100%-owned McDermitt Lithium Project in the US and what it means for the project. The resource is 155 million tonnes at 2,000ppm lithium for...

8 hours, 57 minutes ago

2 min read